We have observed
4 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISORDERS
THICKNESS INCREASE SPRING
PHARMACEUTICAL COMPOSITION FOR TRANSMUCOSAL DELIVERY AND METHODS FOR TREATING DIABETES IN A SUBJECT IN NEED THEREOF
PERK ACTIVATOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES